Related Experiment Videos

Is filtration cost-effective in routine I.V. therapy?

NITA

|May 1, 1984

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Phase II randomised study of magrolimab combined with bevacizumab-FOLFIRI in patients with previously treated advanced inoperable metastatic colorectal cancer.

ESMO gastrointestinal oncology·2026

Treatment attrition between lines of therapy and its impact on outcomes for well-differentiated neuroendocrine tumors in British Columbia.

ESMO gastrointestinal oncology·2026

Systemic adjuvant and perioperative chemotherapy following curative-intent liver metastasectomy in colorectal cancer-is it justified?

ESMO gastrointestinal oncology·2026

ASCEND: a randomised, double-blinded, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel with LSTA1 in untreated metastatic pancreatic adenocarcinoma. An Australasian Gastro-Intestinal Trials Group (AGITG) trial.

ESMO gastrointestinal oncology·2026

Eligibility and workload implications of adjuvant immunotherapy in patients with resected esophageal and gastroesophageal junction (ESO/GEJ) cancer.

ESMO gastrointestinal oncology·2026

Binaural responses to a speech syllable are altered in children with hearing loss: Evidence from the frequency-following response.

Hearing research·2024

See all related articles